Canada markets closed

Biomark Diagnostics Inc (20B.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.1360-0.0190 (-12.26%)
At close: 07:08PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Cash flows from operating activities
Net Income
-1,538
-1,842
-1,454
-1,094
-1,215
Depreciation & amortization
395.064
386.196
179.622
13.686
11.906
Stock based compensation
90.113
329.525
0
395.481
855.895
Change in working capital
-11.675
137.627
42.613
-111.269
-127.303
Accounts Payable
-
-
-
-82.055
-52.079
Other working capital
-946.44
-919.72
-1,263
-807.3
-454.575
Other non-cash items
120.803
74.46
27.74
-8.393
20.999
Net cash provided by operating activites
-943.281
-914.421
-1,204
-807.3
-453.785
Cash flows from investing activities
Investments in property, plant and equipment
-3.159
-5.299
-59.201
-
-0.79
Purchases of investments
-
-
0
-3.2
-
Net cash used for investing activites
-3.159
-5.299
-59.201
-3.2
-0.79
Cash flows from financing activities
Debt repayment
-597.576
-384.986
-310.782
-11.988
-10.187
Common stock issued
1,542
603.195
0
-
709.12
Other financing activites
181.274
268.337
693.944
77.289
185
Net cash used privided by (used for) financing activities
1,126
609.046
768.162
1,076
1,046
Net change in cash
179.132
-310.674
-494.967
265.875
591.809
Cash at beginning of period
133.9
382.711
877.678
611.803
19.994
Cash at end of period
313.032
72.037
382.711
877.678
611.803
Free Cash Flow
Operating Cash Flow
-943.281
-914.421
-1,204
-807.3
-453.785
Capital Expenditure
-3.159
-5.299
-59.201
-
-0.79
Free Cash Flow
-946.44
-919.72
-1,263
-807.3
-454.575